The RNA-editing enzyme ADAR1: a regulatory hub that tunes multiple dsRNA-sensing pathways
International Immunology · 14.03.2023 · 35 (3) · 123-133
DOI: 10.1093/intimm/dxac056 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunology, online erschienen am 05.12.2022. Verfasst von Taisuke Nakahama und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of RNA Biology and Neuroscience, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan. Hauptthemen laut MEDLINE: RNA Editing, RNA, Double-Stranded. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 96 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Ministry of Education, Culture, Sports, Science and Technology, Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Adenosine deaminase acting on RNA 1 (ADAR1) is an RNA-editing enzyme that catalyzes adenosine-to-inosine conversions in double-stranded RNAs (dsRNAs). In mammals, ADAR1 is composed of two isoforms: a nuclear short p110 isoform and a cytoplasmic long p150 isoform. Whereas both isoforms contain right-handed dsRNA-binding and deaminase domains, ADAR1 p150 harbors a Zα domain that binds to left-handed dsRNAs, termed Z-RNAs. Myeloma differentiation-associated gene 5 (MDA5) sensing of endogenous dsRNAs as non-self leads to the induction of type I interferon (IFN)-stimulated genes, but recent studies revealed that ADAR1 p150-mediated RNA editing, but not ADAR1 p110, prevents this MDA5-mediated sensing. ADAR1 p150-specific RNA-editing sites are present and at least a Zα domain–Z-RNA interaction is required for this specificity. Mutations in the ADAR1 gene cause Aicardi–Goutières syndrome (AGS), an infant encephalopathy with type I IFN overproduction. Insertion of a point mutation in the Zα domain of the Adar1 gene induces AGS-like encephalopathy in mice, which is rescued by concurrent deletion of MDA5. This finding indicates that impaired ADAR1 p150-mediated RNA-editing is a mechanism underlying AGS caused by an ADAR1 mutation. ADAR1 p150 also prevents ZBP1 sensing of endogenous Z-RNA, which leads to programmed cell death, via the Zα domain and its RNA-editing activity. Furthermore, ADAR1 prevents protein kinase R (PKR) sensing of endogenous right-handed dsRNAs, which leads to translational shutdown and growth arrest. Thus, ADAR1 acts as a regulatory hub that blocks sensing of endogenous dsRNAs as non-self by multiple sensor proteins, both in RNA editing-dependent and -independent manners, and is a potential therapeutic target for diseases, especially cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of RNA Biology and Neuroscience, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan.
- Integrated Frontier Research for Medical Science Division and RNA Frontier Science Division, Institute for Open and Transdisciplinary Research Initiatives (OTRI), Osaka University, Suita, Osaka 565-0871, Japan.
- Division of Microbiology and Immunology, Center for Infectious Disease Education and Research (CiDER), Osaka University, Suita, Osaka 565-0871, Japan.
ORCID-Profile: Yukio Kawahara
Förderung
- Japan Society for the Promotion of Science
- Ministry of Education, Culture, Sports, Science and Technology
- Japan Agency for Medical Research and Development
- Japan Intractable Diseases Research Foundation
- Astellas Foundation for Research on Metabolic Disorders
- Uehara Memorial Foundation
- Waksman Foundation of Japan
- Senri Life Science Foundation
Zitieren
APA
Nakahama, T., & Kawahara, Y. (2023). The RNA-editing enzyme ADAR1: a regulatory hub that tunes multiple dsRNA-sensing pathways. International Immunology, 35(3), 123-133. https://doi.org/10.1093/intimm/dxac056
Vancouver
Nakahama T, Kawahara Y. The RNA-editing enzyme ADAR1: a regulatory hub that tunes multiple dsRNA-sensing pathways. International Immunology. 2023;35(3):123-133. doi:10.1093/intimm/dxac056
BibTeX
@article{Nakahama2023,
author = {Nakahama, Taisuke and Kawahara, Yukio},
title = {The RNA-editing enzyme ADAR1: a regulatory hub that tunes multiple dsRNA-sensing pathways},
journal = {International Immunology},
year = {2023},
volume = {35},
number = {3},
pages = {123--133},
doi = {10.1093/intimm/dxac056}
}
EUVIMED